Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Atherosclerosis ; 233(2): 704-706, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24583419

RESUMO

BACKGROUND: Impaired endothelial function is the initial step in atherogenesis, which is largely responsible for ischaemic heart disease and thrombotic strokes decades later. METHODS: Fourty two children with first episode nephrotic syndrome (FENS) aged 1-16 years and 40 controls were enrolled. Soluble thrombomodulin (sTM), tissue plasminogen activator (t-PA), plasminogen activator inhibitor -1 (PAI-1) and von-willebrand factor (vWF) levels were measured in plasma in FENS, at 12 weeks of drug induced remission and in steroid resistant nephrotic syndrome (SRNS) patients at diagnosis. RESULTS: PAI-1, sTM, vWF and t-PA were significantly raised at the onset of nephrotic syndrome (p<0.0001). All the markers had a fall after 12 weeks of steroid treatment, but were still raised. Children with SRNS had higher levels of sTM, tPA, vWF as compared to infrequent relapsers, at onset and at 4 weeks of steroid treatment. CONCLUSION: Children with idiopathic nephrotic syndrome have endothelial dysfunction which is largely dependent upon disease activity.


Assuntos
Endotélio Vascular/fisiopatologia , Síndrome Nefrótica/fisiopatologia , Adolescente , Corticosteroides/uso terapêutico , Biomarcadores , Criança , Pré-Escolar , Resistência a Medicamentos , Feminino , Seguimentos , Humanos , Lactente , Lipídeos/sangue , Masculino , Síndrome Nefrótica/sangue , Síndrome Nefrótica/tratamento farmacológico , Inibidor 1 de Ativador de Plasminogênio/sangue , Recidiva , Trombomodulina/sangue , Ativador de Plasminogênio Tecidual/sangue , Fator de von Willebrand/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...